Saturday, April 25, 2026

Samchundang Pharm Announces 250 Billion KRW Stake Sale…Expectations Rise for Future Growth

Samchundang Pharm's CEO plans a 2.5 billion KRW share sale for tax purposes, hinting at significant news and future growth in pharma.

U.S. and South Korean Forces Build Bridge to Cooperation

th Engineer Brigade of the Army announced that it is conducting a joint river crossing exercise with the U.S. 2nd Division.

Kim Jong Un Balances Fish Farms and Families Before Turning to China

Kim Jong Un prioritizes domestic achievements, focusing on public welfare and unity before his upcoming trip to China.

Tag: Herzuma

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Celltrion’s Breakthrough: Why Vegzelma and Herzuma Lead in Japan’s Oncology Market

Celltrion's cancer treatments dominate the Japanese market, with Vegzelma and Herzuma capturing significant shares, showcasing strong growth.

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.